Skip to main content
Top
Published in: Virology Journal 1/2016

Open Access 01-12-2016 | Research

Seroprevalence of Orthopoxvirus in rural Brazil: insights into anti-OPV immunity status and its implications for emergent zoonotic OPV

Authors: Galileu Barbosa Costa, Lídia Teodoro Santos Augusto, Juliana Almeida Leite, Paulo César Peregrino Ferreira, Cláudio Antônio Bonjardim, Jônatas Santos Abrahão, Erna Geessien Kroon, Elizabeth Castro Moreno, Giliane de Souza Trindade

Published in: Virology Journal | Issue 1/2016

Login to get access

Abstract

Background

Bovine vaccinia (BV) is a zoonosis caused by Vaccinia virus, a virus from Orthopoxvirus genus (OPV) that affects mainly cattle herds and humans in rural areas in Brazil. Because most studies have focused on outbreaks situations, data on BV epidemiology is limited. A cross sectional study in Brazilian rural areas during 2012–2013 was conducted to determine the neutralizing antibodies seroprevalence and risk factors for BV.

Methods

A structured questionnaire was applied to elicit demographics data and farming practices considered risk factors for BV exposure. Neutralizing anti-OPV antibodies were investigated using plaque reduction neutralization test. The neutralizing antibodies prevalence rates were calculated and the risk factor analysis was performed using multivariate logistic regression.

Results

Two hundred and forty participants were enrolled in this study with a prevalence of neutralizing antibodies of 30.8 % (95 % confidence interval [CI], 25.3–36.9). In multivariate analysis, age > 35 years (Odds Ratio [OR] = 18.2; CI 95 % = 7.7 – 43.2) and previous outbreak in property (OR = 3.9; C I95 % = 1.2 – 12.6) were independently associated with anti-OPV neutralizing antibodies.

Conclusions

In this study, anti-OPV protective immunity (neutralizing antibody titers) was assessed in an endemic BV Brazilian rural area. Our findings indicate that epidemiological surveillance is required and should be applied by public health authorities to create interventions and/or prevention strategies to avoid viral spread causing future outbreaks among individuals who are under risk of infection.
Literature
1.
go back to reference Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi I. Smallpox and its eradication. Geneva: World Health Organization; 1988. Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi I. Smallpox and its eradication. Geneva: World Health Organization; 1988.
2.
go back to reference Isaacs SN. Working safely with vaccinia virus: laboratory technique and review of published cases of accidental laboratory infections. Vaccinia virus and poxvirology: methods and protocols, chapter 1. Method Mol Biol. 2012;890:1–21.CrossRef Isaacs SN. Working safely with vaccinia virus: laboratory technique and review of published cases of accidental laboratory infections. Vaccinia virus and poxvirology: methods and protocols, chapter 1. Method Mol Biol. 2012;890:1–21.CrossRef
4.
go back to reference Rimoin AW, Kisalu N, Kebela-Ilunga B, Mukaba T, Wright LL, Formenty P, et al. Endemic human monkeypox, Democratic Republic of Congo, 2001–2004. Emerg Infect Dis. 2007;13:934–7.CrossRefPubMedPubMedCentral Rimoin AW, Kisalu N, Kebela-Ilunga B, Mukaba T, Wright LL, Formenty P, et al. Endemic human monkeypox, Democratic Republic of Congo, 2001–2004. Emerg Infect Dis. 2007;13:934–7.CrossRefPubMedPubMedCentral
5.
go back to reference Lederman ER, Reynolds MG, Karem K, Braden Z, Learned-Orozco LA, Wassa-Wassa D, et al. Prevalence of Antibodies against Orthopoxviruses among Residents of Likouala Region, Republic of Congo: Evidence for Monkeypox Virus Exposure. Am J Trop Med Hyg. 2007;77:1150–6.PubMed Lederman ER, Reynolds MG, Karem K, Braden Z, Learned-Orozco LA, Wassa-Wassa D, et al. Prevalence of Antibodies against Orthopoxviruses among Residents of Likouala Region, Republic of Congo: Evidence for Monkeypox Virus Exposure. Am J Trop Med Hyg. 2007;77:1150–6.PubMed
6.
go back to reference Reed KD, Melski JW, Graham MB, Regnery RL, Sotir MJ, Wegner MV, et al. The detection of monkeypox in humans in the Western Hemisphere. N Engl J Med. 2004;350:342–50. Reed KD, Melski JW, Graham MB, Regnery RL, Sotir MJ, Wegner MV, et al. The detection of monkeypox in humans in the Western Hemisphere. N Engl J Med. 2004;350:342–50.
8.
go back to reference Singh RK, Balamurugan V, Bhanuprakash V, Venkatesan G, Hosamani M. Emergence and Reemergence of Vaccinia-Like Viruses: Global Scenario and Perspectives. Indian J Virol. 2012;23:1–11.CrossRefPubMedPubMedCentral Singh RK, Balamurugan V, Bhanuprakash V, Venkatesan G, Hosamani M. Emergence and Reemergence of Vaccinia-Like Viruses: Global Scenario and Perspectives. Indian J Virol. 2012;23:1–11.CrossRefPubMedPubMedCentral
9.
go back to reference Vora NM, Li Y, Geleishvili M, Emerson GL, Khmaladze E, Maghlakelidze G, et al. Human Infection with a Zoonotic Orthopoxvirus in the Country of Georgia. N Engl J Med. 2015;372:1223–30.CrossRefPubMedPubMedCentral Vora NM, Li Y, Geleishvili M, Emerson GL, Khmaladze E, Maghlakelidze G, et al. Human Infection with a Zoonotic Orthopoxvirus in the Country of Georgia. N Engl J Med. 2015;372:1223–30.CrossRefPubMedPubMedCentral
10.
go back to reference Kannangai R, Finny GJ, John TJ, Sridharan G, Gopal R. Vaccinia Reactive Antibodies in a South Indian Population. J Med Virol. 2000;62:293–7.CrossRefPubMed Kannangai R, Finny GJ, John TJ, Sridharan G, Gopal R. Vaccinia Reactive Antibodies in a South Indian Population. J Med Virol. 2000;62:293–7.CrossRefPubMed
11.
go back to reference Huhn GD, Bauer AM, Yorita K, Graham MB, Sejvar J, Likos A, et al. Clinical Characteristics of Human Monkeypox, and Risk Factors for Severe Disease. Clin Infect Dis. 2005;41:1742–51.CrossRefPubMed Huhn GD, Bauer AM, Yorita K, Graham MB, Sejvar J, Likos A, et al. Clinical Characteristics of Human Monkeypox, and Risk Factors for Severe Disease. Clin Infect Dis. 2005;41:1742–51.CrossRefPubMed
12.
go back to reference Karem KL, Reynolds M, Hughes C, Braden Z, Nigam P, Crotty S, et al. Monkeypox-Induced Immunity and Failure of Childhood Smallpox Vaccination To Provide Complete Protection. Clin Vaccine Immunol. 2007;14:1318–27.CrossRefPubMedPubMedCentral Karem KL, Reynolds M, Hughes C, Braden Z, Nigam P, Crotty S, et al. Monkeypox-Induced Immunity and Failure of Childhood Smallpox Vaccination To Provide Complete Protection. Clin Vaccine Immunol. 2007;14:1318–27.CrossRefPubMedPubMedCentral
13.
go back to reference Silva-Fernandes AT, Travassos CE, Ferreira JM, Abrahão JS, Rocha ES, Viana-Ferreira F, et al. Natural human infections with Vaccinia virus during bovine vaccinia outbreaks. J Clin Virol. 2009;44:308–13.CrossRefPubMed Silva-Fernandes AT, Travassos CE, Ferreira JM, Abrahão JS, Rocha ES, Viana-Ferreira F, et al. Natural human infections with Vaccinia virus during bovine vaccinia outbreaks. J Clin Virol. 2009;44:308–13.CrossRefPubMed
14.
go back to reference Mota BEF, Trindade GS, Diniz TC, da Silva-Nunes M, Braga EM, Urbano-Ferreira M, et al. Seroprevalence of orthopoxvirus in an Amazonian rural village, Acre. Brazil Arch Virol. 2010;155:1139–44.CrossRefPubMed Mota BEF, Trindade GS, Diniz TC, da Silva-Nunes M, Braga EM, Urbano-Ferreira M, et al. Seroprevalence of orthopoxvirus in an Amazonian rural village, Acre. Brazil Arch Virol. 2010;155:1139–44.CrossRefPubMed
15.
go back to reference Macneil A, Abel J, Reynolds MG, Lash R, Fonnie R, Kanneh LD, et al. Serologic evidence of human orthopoxvirus infections in Sierra Leone. BMC Res Notes. 2011;4:465.CrossRefPubMedPubMedCentral Macneil A, Abel J, Reynolds MG, Lash R, Fonnie R, Kanneh LD, et al. Serologic evidence of human orthopoxvirus infections in Sierra Leone. BMC Res Notes. 2011;4:465.CrossRefPubMedPubMedCentral
16.
go back to reference Figueiredo PO, Silva-Fernandes AT, Mota BEF, Costa GB, Borges IA, Ferreira PCP, et al. Evaluating anti-Orthopoxvirus antibodies in individuals from Brazil rural areas prior to the Bovine Vaccine era. Mem Inst Oswaldo Cruz. 2015;110(6):804–8.CrossRefPubMedCentral Figueiredo PO, Silva-Fernandes AT, Mota BEF, Costa GB, Borges IA, Ferreira PCP, et al. Evaluating anti-Orthopoxvirus antibodies in individuals from Brazil rural areas prior to the Bovine Vaccine era. Mem Inst Oswaldo Cruz. 2015;110(6):804–8.CrossRefPubMedCentral
17.
go back to reference Schatzmayr HG, Costa RVC, Gonçalves MCR, D'Andréa PS, Barth OM. Human and animal infections by vaccinia-like viruses in the state of Rio de Janeiro: A novel expanding zoonisis. Vaccine. 2011;29 Suppl 4:D65–9.CrossRefPubMed Schatzmayr HG, Costa RVC, Gonçalves MCR, D'Andréa PS, Barth OM. Human and animal infections by vaccinia-like viruses in the state of Rio de Janeiro: A novel expanding zoonisis. Vaccine. 2011;29 Suppl 4:D65–9.CrossRefPubMed
18.
go back to reference da Fonseca FG, Kroon EG, Nogueira ML, Trindade GS. Zoonotic vaccinia virus outbreaks in Brazil. Future Virol. 2011;6:697–707.CrossRef da Fonseca FG, Kroon EG, Nogueira ML, Trindade GS. Zoonotic vaccinia virus outbreaks in Brazil. Future Virol. 2011;6:697–707.CrossRef
19.
go back to reference Kroon EG, Mota BEF, Abrahão JS, da Fonseca FG, de Souza Trindade G. Zoonotic Brazilian vaccinia virus: from field to therapy. Antivir Res. 2011;92:150–63.CrossRefPubMed Kroon EG, Mota BEF, Abrahão JS, da Fonseca FG, de Souza Trindade G. Zoonotic Brazilian vaccinia virus: from field to therapy. Antivir Res. 2011;92:150–63.CrossRefPubMed
20.
go back to reference Megid J, Appolinário CM, Langoni H, Pituco EM, Okuda LH. Vaccinia Virus in Humans and Cattle in Southwest Region of São Paulo State. Brazil Am J Trop Med Hyg. 2008;79:647–51.PubMed Megid J, Appolinário CM, Langoni H, Pituco EM, Okuda LH. Vaccinia Virus in Humans and Cattle in Southwest Region of São Paulo State. Brazil Am J Trop Med Hyg. 2008;79:647–51.PubMed
21.
go back to reference Abrahão JS, Campos RK, Trindade GS. Guimarães da Fonseca F, Ferreira PC, Kroon EG. Outbreak of severe zoonotic vaccinia virus infection, Southeastern Brazil. Emerg Infect Dis. 2015;21:695–8.CrossRefPubMedPubMedCentral Abrahão JS, Campos RK, Trindade GS. Guimarães da Fonseca F, Ferreira PC, Kroon EG. Outbreak of severe zoonotic vaccinia virus infection, Southeastern Brazil. Emerg Infect Dis. 2015;21:695–8.CrossRefPubMedPubMedCentral
22.
go back to reference Kennedy RB, Ovsyannikova IG, Pankratz VS, Vierkant RA, Jacobson RM, Ryan MA, et al. Gender effects on humoral immune responses to smallpox vaccine. Vaccine. 2009;27:3319–23.CrossRefPubMedPubMedCentral Kennedy RB, Ovsyannikova IG, Pankratz VS, Vierkant RA, Jacobson RM, Ryan MA, et al. Gender effects on humoral immune responses to smallpox vaccine. Vaccine. 2009;27:3319–23.CrossRefPubMedPubMedCentral
23.
go back to reference Newman FK, Frey SE, Blevins TP, Mandava M, Bonifacio Jr A, Yan L, et al. Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine. J Clin Microbiol. 2003;41:3154–517.CrossRefPubMedPubMedCentral Newman FK, Frey SE, Blevins TP, Mandava M, Bonifacio Jr A, Yan L, et al. Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine. J Clin Microbiol. 2003;41:3154–517.CrossRefPubMedPubMedCentral
24.
go back to reference Costa GB, Moreno EC, de Souza TG, Studies Group in Bovine Vaccinia. Neutralizing antibodies associated with exposure factors to Orthopoxvirus in laboratory workers. Vaccine. 2013;31:4706–9.CrossRefPubMed Costa GB, Moreno EC, de Souza TG, Studies Group in Bovine Vaccinia. Neutralizing antibodies associated with exposure factors to Orthopoxvirus in laboratory workers. Vaccine. 2013;31:4706–9.CrossRefPubMed
25.
go back to reference Hammarlund E, Lewis MW, Hansen SG, Strelow LI, Nelson JA, Sexton GJ, et al. Duration of antiviral immunity after smallpox vaccination. Nat Med. 2003;9:1131–7.CrossRefPubMed Hammarlund E, Lewis MW, Hansen SG, Strelow LI, Nelson JA, Sexton GJ, et al. Duration of antiviral immunity after smallpox vaccination. Nat Med. 2003;9:1131–7.CrossRefPubMed
26.
go back to reference Hsieh SM, Pan SC, Chen SY, Huang PF, Chang SC. Age Distribution for T Cell Reactivity to Vaccinia Virus in a Healthy Population. Clin Infect Dis. 2004;38:86–9.CrossRefPubMed Hsieh SM, Pan SC, Chen SY, Huang PF, Chang SC. Age Distribution for T Cell Reactivity to Vaccinia Virus in a Healthy Population. Clin Infect Dis. 2004;38:86–9.CrossRefPubMed
27.
go back to reference Hatakeyama S, Moriya K, Saijo M, Morisawa Y, Kurane I, Koike K, et al. Persisting humoral antiviral immunity within the Japanese population after the discontinuation in 1976 of routine smallpox vaccinations. Clin Diagn Lab Immunol. 2005;12:520–4.PubMedPubMedCentral Hatakeyama S, Moriya K, Saijo M, Morisawa Y, Kurane I, Koike K, et al. Persisting humoral antiviral immunity within the Japanese population after the discontinuation in 1976 of routine smallpox vaccinations. Clin Diagn Lab Immunol. 2005;12:520–4.PubMedPubMedCentral
28.
go back to reference Putz MM, Alberini I, Midgley CM, Manini I, Montomoli E, Smith GL. Prevalence of antibodies to vaccinia virus after smallpox vaccination in Italy. J Gen Virol. 2005;86:2955–60.CrossRefPubMed Putz MM, Alberini I, Midgley CM, Manini I, Montomoli E, Smith GL. Prevalence of antibodies to vaccinia virus after smallpox vaccination in Italy. J Gen Virol. 2005;86:2955–60.CrossRefPubMed
29.
go back to reference Viner KM, Isaacs SN. Activity of vaccinia-virus neutralizing antibody in the sera of smallpox vaccines. Microbes Infect. 2005;7:579–83.CrossRefPubMed Viner KM, Isaacs SN. Activity of vaccinia-virus neutralizing antibody in the sera of smallpox vaccines. Microbes Infect. 2005;7:579–83.CrossRefPubMed
30.
go back to reference Taub DD, Ershler WB, Janowski M, Artz A, Key ML, McKelvey J, et al. Immunity from Smallpox Vaccine Persists for Decades: A Longitudinal Study. Am J Med. 2008;121:1058–64.CrossRefPubMedPubMedCentral Taub DD, Ershler WB, Janowski M, Artz A, Key ML, McKelvey J, et al. Immunity from Smallpox Vaccine Persists for Decades: A Longitudinal Study. Am J Med. 2008;121:1058–64.CrossRefPubMedPubMedCentral
31.
go back to reference Liu Q, Huang W, Nie J, Zhu R, Gao D, Song A, et al. A Novel High-Throughput Vaccinia Virus Neutralization Assay and Preexisting Immunity in Populations from Different Geographic Regions in China. PLoS One. 2012;7, e33392.CrossRefPubMedPubMedCentral Liu Q, Huang W, Nie J, Zhu R, Gao D, Song A, et al. A Novel High-Throughput Vaccinia Virus Neutralization Assay and Preexisting Immunity in Populations from Different Geographic Regions in China. PLoS One. 2012;7, e33392.CrossRefPubMedPubMedCentral
32.
go back to reference Trindade GS, Guedes MIC, Drumond BP, Mota BE, Abrahão JS, Lobato ZI, et al. Zoonotic Vaccinia Virus: Clinical and Immunological Characteristics in a Naturally Infected Patient. Clin Infect Dis. 2009;48:e37–40.CrossRefPubMed Trindade GS, Guedes MIC, Drumond BP, Mota BE, Abrahão JS, Lobato ZI, et al. Zoonotic Vaccinia Virus: Clinical and Immunological Characteristics in a Naturally Infected Patient. Clin Infect Dis. 2009;48:e37–40.CrossRefPubMed
33.
go back to reference Assis FL, Borges IA, Ferreira PC, Bonjardim CA, Trindade GS, Lobato ZI, et al. Group 2 Vaccinia Virus. Brazil Emerg Infect Dis. 2012;18:2035–8.CrossRefPubMed Assis FL, Borges IA, Ferreira PC, Bonjardim CA, Trindade GS, Lobato ZI, et al. Group 2 Vaccinia Virus. Brazil Emerg Infect Dis. 2012;18:2035–8.CrossRefPubMed
34.
go back to reference Costa GB, Borges IA, Alves PA, Miranda JB, Franco-Luiz AP, Ferreira PC, et al. Alternative routes of zoonotic Vaccinia virus transmission. Brazil Emerg Infect Dis. 2015;21:2244–6.CrossRefPubMed Costa GB, Borges IA, Alves PA, Miranda JB, Franco-Luiz AP, Ferreira PC, et al. Alternative routes of zoonotic Vaccinia virus transmission. Brazil Emerg Infect Dis. 2015;21:2244–6.CrossRefPubMed
35.
go back to reference Reynolds MG, Carroll DS, Olson VA, Hughes C, Galley J, Likos A, et al. A silent enzootic of an orthopoxvirus in Ghana, West Africa: Evidence for multi-species involvement in the absence of widespread human disease. Am J Trop Med Hyg. 2010;82:746–54.CrossRefPubMedPubMedCentral Reynolds MG, Carroll DS, Olson VA, Hughes C, Galley J, Likos A, et al. A silent enzootic of an orthopoxvirus in Ghana, West Africa: Evidence for multi-species involvement in the absence of widespread human disease. Am J Trop Med Hyg. 2010;82:746–54.CrossRefPubMedPubMedCentral
36.
go back to reference Reynolds MG, Damon IK. Outbreaks of human monkeypox after cessation of smallpox vaccination. Trends Microbiol. 2012;20(2):80–7.CrossRefPubMed Reynolds MG, Damon IK. Outbreaks of human monkeypox after cessation of smallpox vaccination. Trends Microbiol. 2012;20(2):80–7.CrossRefPubMed
Metadata
Title
Seroprevalence of Orthopoxvirus in rural Brazil: insights into anti-OPV immunity status and its implications for emergent zoonotic OPV
Authors
Galileu Barbosa Costa
Lídia Teodoro Santos Augusto
Juliana Almeida Leite
Paulo César Peregrino Ferreira
Cláudio Antônio Bonjardim
Jônatas Santos Abrahão
Erna Geessien Kroon
Elizabeth Castro Moreno
Giliane de Souza Trindade
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2016
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-016-0575-6

Other articles of this Issue 1/2016

Virology Journal 1/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.